A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...

But in the 1990s the virus that causes AIDS turned out to offer a solution. Researchers discovered how to strip away HIV’s destructive genes and repurpose it as a “lentiviral vector”—a tool to deliver ...

Is there a vaccine for the Nipah virus? Early human trials show a new vaccine is safe and triggers strong immune responses.

This is one in a series looking at what Lake County communities, agencies, and school districts experienced in 2025 and what ...

Betting everything on a single growth stock carries massive danger, but in this thought experiment, ChatGPT endorsed a FTSE ...

Ultragenyx Pharmaceutical (RARE) stock is in focus as the company completes FDA rolling submission for FDA approval of its ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 2, 2026 /CNW/ — Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by ...

Plymouth Meeting, Pennsylvania Tuesday, December 30, 2025, 15:00 Hrs [IST] ...

Suddenly, one day, creatine was everywhere, being talked up by every fitness influencer, mental health guru and powder ...

The FDA assigned INO-3107 a Prescription Drug User Fee Act (PDUFA) review goal date of October 30, 2026, which is the date by which it intends to take action on the application. The FDA has indicated ...